HALO logo
halo search icon
111, Inc. Sponsored ADR

US$5.73

Price Change Indicator
-0.05 (-0.865%)
111, Inc. Sponsored ADR
YI · NAS

111, Inc. Sponsored ADR

Start Trading YI for Free

US$5.73

Price Arrow-0.05 (-0.865%)
20/05/2026 04:00:00 PM
All-ConsensusBig CandleHammer Bearish
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

111, Inc. Sponsored ADR Overview

YI Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About YI

icon
icon

Telephone

86.21.2053.6666

icon

Address

3-4 Floor, Pudong New Area, No.295 Zuchongzhi Road, Shanghai 201203

Description

111, Inc. Is a holding company, which engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.

YI Price Chart

Key Stats

Market Cap

US$29.29M

PE

0.00

EV/EBITDA

435.8

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 2.48 - 11.17

Trade Value (12mth)

US$32,754.00

1 week

-0.17%

1 month

-15.87%

YTD

109.42%

1 year

-25.9%

All time high

458.80

Key Fundamentals

EPS 3 yr Growth

-84.70%

EBITDA Margin

0.00%

Operating Cashflow

¥119m

Free Cash Flow Return

0.00%

ROIC

0.00%

Interest Coverage

0.00

Quick Ratio

0.60

Other Data

Shares Outstanding (Fully Diluted)

9m

HALO Sector

Healthcare

Next Company Report Date

03-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

CNY

Short Sell (% of issue)

0.00

YI Announcements

Latest Announcements

DateAnnouncements
30 April 26
30 April 26
09 April 26
17 January 26
17 January 26

YI Fundamentals

Per Share Records

Historical data

Forecast data

CNY2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 ¥locklocklocklock-46.48-7.51-7.63locklocklock
EPS (Fully Diluted)
 ¥locklocklocklock-46.48-7.51-7.63locklocklock
Growth
 %locklocklocklock6.983.8-1.5locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/A100.3435.8locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of 111, Inc. Sponsored ADR (YI:NAS)?
Halo FAQ
The current share price of 111, Inc. Sponsored ADR (YI:NAS) is USD$5.73.
What is the 52-week high share price for 111, Inc. Sponsored ADR (YI:NAS)?
Halo FAQ
The 52-week high share price for 111, Inc. Sponsored ADR (YI:NAS) is USD$11.17.
What is the 52-week low share price for 111, Inc. Sponsored ADR (YI:NAS)?
Halo FAQ
The 52-week low share price for 111, Inc. Sponsored ADR (YI:NAS) is USD$2.48.
What is the dividend yield for 111, Inc. Sponsored ADR (YI:NAS)?
Halo FAQ
111, Inc. Sponsored ADR (YI:NAS) does not pay a dividend.
What was 111, Inc. Sponsored ADR (YI:NAS) last dividend payment?
Halo FAQ
111, Inc. Sponsored ADR (YI:NAS) does not pay a dividend.
What is the franking level for 111, Inc. Sponsored ADR (YI:NAS)?
Halo FAQ
111, Inc. Sponsored ADR (YI:NAS) has a franking level of 0.00%.
In which sector is 111, Inc. Sponsored ADR (YI:NAS) classified?
Halo FAQ
111, Inc. Sponsored ADR (YI:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial